GNAS and myxoma: Thus, assays targeting only these pathogenic variants, p.R201C and p.R201H, such as pyrosequencing, quantitative real-time PCR, and digital PCR should be used with caution for the detection of GNAS pathogenic variants in intramuscular myxomas [20, 21, 59, 60].